BCMA/CD19 dual-targeted CAR-T cell therapy

· Nanjing University School of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BCMA/CD19 dual-targeted CAR-T cell therapy, covering 2025-06-11 to 2025-06-11. Get the full timeline:

Most recent: Clinical Trial Update: The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases [Phase 1]